NEU 0.85% $15.14 neuren pharmaceuticals limited

Share Price, page-3850

  1. 236 Posts.
    lightbulb Created with Sketch. 37

    Very good points Guzz - I like your positive attitude/logic around the possibility of FDA approval !

    With your final point - I think this is maybe one of the reasons why NEU management have held off on announcing/finalizing the ROW rights deal.

    We get the DOUBLE WHAMMY of FDA Approval and ROW deal in quite quick succession - then we will really fly !!
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.